$PIQ (I don't rate trendlines but this is a beauty)ASX:PIQ Weakly lifting on volume and resting on the trendline. one more pull back to screw the punters and then she blows. IMO etc etc.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.055 AUD
−6.38 M AUD
892.14 K AUD
91.96 M
About PROTEOMICS INTERNATIONAL LABORATORIES LTD
Sector
Industry
CEO
Richard Lipscombe
Website
Headquarters
Perth
Founded
2001
ISIN
AU000000PIQ0
FIGI
BBG007HW1G08
Proteomics International Laboratories Ltd. is a medical technology company which operates at the forefront of predictive diagnostics and bio-analytical services. The company was founded by Richard Lipscombe and Bill Parker in 2001 and is headquartered in Perth, Australia.
$PIQ cr at 77 this week. Right on support.Lots of newsflow on this thing coming. Ive drawn a speculative red curve. These raises inevitably test the raise price and double whammy with director Dick selling shares.
Having said that I reckon they'll have great newsflow this year and Europe agreements should be the highest priority along
$PIQ nice run here. BUllflag. DIMI!!!Bullflag.
I expect. deep pullback once she hits the top rail so I'll let go before then. I'll watch for a re-entry after that.
$PIQ news reentry into wedge.very good risk reward play here in my opionion. Bought the change in momo back up into that wedge. Sell some at the top of the range and hopefully another catalyst breaks it out to the topside. time will tell.
$PIQ - Proteomics International continuing its rapid climb$PIQ - Proteomics International continuing its rapid climb
Good little stock with lots of momentum. All my indicators are headed in the right direction - probably a bit expensive at the moment based on the RSI - but with diabetes being the next big global disease especially in the western world Ill
memory of the last peakEnter a dragon den with this little stock , as always with Biotech , hard to tell which way it will end up , just like bitcoin.
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of PIQ is 0.445 AUD — it has decreased by −1.11% in the past 24 hours. Watch PROTEOMICS INTERNATIONAL LABORATORIES LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange PROTEOMICS INTERNATIONAL LABORATORIES LTD stocks are traded under the ticker PIQ.
PIQ stock has fallen by −1.11% compared to the previous week, the month change is a −10.10% fall, over the last year PROTEOMICS INTERNATIONAL LABORATORIES LTD has showed a −61.14% decrease.
We've gathered analysts' opinions on PROTEOMICS INTERNATIONAL LABORATORIES LTD future price: according to them, PIQ price has a max estimate of 0.72 AUD and a min estimate of 0.50 AUD. Watch PIQ chart and read a more detailed PROTEOMICS INTERNATIONAL LABORATORIES LTD stock forecast: see what analysts think of PROTEOMICS INTERNATIONAL LABORATORIES LTD and suggest that you do with its stocks.
PIQ stock is 2.27% volatile and has beta coefficient of 1.37. Track PROTEOMICS INTERNATIONAL LABORATORIES LTD stock price on the chart and check out the list of the most volatile stocks — is PROTEOMICS INTERNATIONAL LABORATORIES LTD there?
Yes, you can track PROTEOMICS INTERNATIONAL LABORATORIES LTD financials in yearly and quarterly reports right on TradingView.
PROTEOMICS INTERNATIONAL LABORATORIES LTD is going to release the next earnings report on Sep 2, 2025. Keep track of upcoming events with our Earnings Calendar.
PROTEOMICS INTERNATIONAL LABORATORIES LTD revenue for the last half-year amounts to 962.42 K AUD, despite the estimated figure of 600.00 K AUD. In the next half-year revenue is expected to reach 3.20 M AUD.
PIQ net income for the last half-year is −4.49 M AUD, while the previous report showed −2.62 M AUD of net income which accounts for −70.99% change. Track more PROTEOMICS INTERNATIONAL LABORATORIES LTD financial stats to get the full picture.
No, PIQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PROTEOMICS INTERNATIONAL LABORATORIES LTD EBITDA is −9.01 M AUD, and current EBITDA margin is −916.56%. See more stats in PROTEOMICS INTERNATIONAL LABORATORIES LTD financial statements.
Like other stocks, PIQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROTEOMICS INTERNATIONAL LABORATORIES LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PROTEOMICS INTERNATIONAL LABORATORIES LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PROTEOMICS INTERNATIONAL LABORATORIES LTD stock shows the sell signal. See more of PROTEOMICS INTERNATIONAL LABORATORIES LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.